It's not dilution. It's the shareholders trading
Post# of 22940
With over 8 billion issued common shares it's easy to look at this as a hopeless whale that will never, short of a pump, make it as a successful business with product that people want. Hence, the bottom feeders that aren't interested in bearings, or e-bikes, or whatever can have a manipulative effect on the stock price. I can't say I blame them. Isn't it everyone's purpose when investing to make money? Buy low, sell high.
There are funds set aside for a share buyback but that won't happen until some kind of revenue stream is established. After all, from a business standpoint, what's the point of buying back and retiring less than half of the shares if you've got creditors that are at the gates? Since we don't have a current 10-K or Q to look at, you have to speculate, or guess. Someone else commented on this but there is probably more than a little truth to it; for the creditors to agree to pushing the debt down the road, Bill must have given them a good enough reason to wait. Maybe they were able to see a ledger that contained e-bike PO's. Who knows. But at least we've got until July before the debt is due and a CEO that is at least trying to do something about that.
If you're wondering how the the authorized has gone from 3 billion to 8 billion in such a short amount of time, read the 10-Q's. Here's an example of convertible debt in the form of notes from page 30 of the last 10-Q:
ITEM 2 – UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
4. On May 12, 2017, we issued 58,187,135 shares of our common stock upon conversion of convertible notes. The issuance was exempt in reliance upon the exemption provided by Rule 4(a)(2) and/or Rule 506 of the Securities Act of 1933.
5. On May 23, 2017, we issued 277,777,778 shares of our common stock upon conversion of convertible notes. The issuance was exempt in reliance upon the exemption provided by Rule 4(a)(2) and/or Rule 506 of the Securities Act of 1933.
6. On July 14, 2017, we issued 420,000,000 shares of our common stock upon conversion of 420_______ shares of our Series A Convertible Preferred Stock. The issuances were exempt in reliance upon the exemption provided by Rule 3(a)(9) and/or Section 4(a)(2) of the Securities Act of 1933
7. On July 18, 2017, we issued 287,547,166 shares of our common stock upon conversion of convertible notes. The issuance was exempt in reliance upon the exemption provided by Rule 4(a)(2) and/or Rule 506 of the Securities Act of 1933.
8. On July 19, 2017, we issued 389,000,000 shares of our common stock upon conversion of 389______ shares of our Series A Convertible Preferred Stock. The issuances were exempt in reliance upon the exemption provided by Rule 3(a)(9) and/or Section 4(a)(2) of the Securities Act of 1933.
9. On September 6, 2017, we issued 324,620,000 shares of our common stock upon conversion of convertible notes. The issuance was exempt in reliance upon the exemption provided by Rule 3(a)(9) and/or Section 4(a)(2) of the Securities Act of 1933.
10. On September 6, 2017, we issued 324,620,000 shares of our common stock upon conversion of convertible notes. The issuance was exempt in reliance upon the exemption provided by Rule 3(a)(9) and/or Section 4(a)(2) of the Securities Act of 1933.
11. On September 7, 2017, we issued 194,500,000 shares of our common stock upon conversion of convertible notes. The issuance was exempt in reliance upon the exemption provided by Rule 3(a)(9) and/or Section 4(a)(2) of the Securities Act of 1933.
That's just shy of 2.3 billion shares. The price of doing business without any substantial form of income. Why is this company still floating after all these years of no revenue? It's Bill. He's got a plan and he's trying to implement it. I think it's gone sideways a little due to funding issues and maybe a little concern on the part of potential clients as to TPAC's ability to produce (no track record) but he's working his way through them. Bill has some pretty good ideas that haven't panned out yet, but probably will. I'll say one thing for him, he's persistent. But after all, isn't that why we're in the OTC? A gamble on what seems to be a good idea that a few thousand dollars invested can result in the big payoff.
It's like a drug. It's us.